0000914190-21-000185.txt : 20210616 0000914190-21-000185.hdr.sgml : 20210616 20210616192216 ACCESSION NUMBER: 0000914190-21-000185 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210614 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kummeth Charles R. CENTRAL INDEX KEY: 0001534980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 211022863 MAIL ADDRESS: STREET 1: 425 MARTINGALE ROAD STREET 2: SUITE 1000 CITY: SCHAUMBURG STATE: IL ZIP: 60173-2213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-06-14 0000842023 BIO-TECHNE Corp TECH 0001534980 Kummeth Charles R. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 1 0 0 Chief Executive Officer Common Stock 2021-06-14 4 S 0 7132 449.1 D 167253 D Common Stock 2021-06-14 4 S 0 349 450.1 D 166904 D Common Stock 100 I By Step-Son Common Stock 100 I By Step-Daughter Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 95346 95346 D Stock Options (Right to Buy) 108.49 2022-08-07 Common Stock 79517 79517 D Stock Options (Right to Buy) 106.59 2023-08-18 Common Stock 154169 154169 D Stock Options (Right to Buy) 106.59 2023-08-18 Common Stock 102779 102779 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 117342 117342 D Stock Options (Right to Buy) 125.05 2024-08-09 Common Stock 78228 78228 D Restricted Stock Units Common Stock 16918 16918 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 90334 90334 D Stock Options (Right to Buy) 177.32 2025-08-08 Common Stock 60222 60222 D Restricted Stock Units Common Stock 16937 16937 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 85725 85725 D Stock Options (Right to Buy) 190.41 2026-08-07 Common Stock 57150 57150 D Restricted Stock Units Common Stock 12879 12879 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 57442 57442 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 38295 38295 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 16650.0 16650.0 D Stock Options (Right to Buy) 267.87 2027-08-05 Common Stock 16650 16650 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 18, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.00 to $449.97, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 3,759 shares of restricted stock for which the risk of forfeiture will lapse on August 8, 2021; (ii) 7,527 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on August 7, 2021 and as to 3,763 shares on August 7, 2022; and (iii) 8,586 shares of restricted stock for which the risk of forfeiture will lapse as to 2,862 shares on each of August 5, 2021, August 5, 2022 and August 5, 2023. Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Options to purchase 19,557 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021. Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022. Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021. Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23. /s/ Brenda S. Furlow as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney previously filed. 2021-06-16